2019
DOI: 10.1016/j.regg.2019.06.004
|View full text |Cite
|
Sign up to set email alerts
|

Población muy anciana institucionalizada de Barcelona: valoración de la fragilidad según el índice frágil-VIG y análisis de la adecuación terapéutica según los criterios STOPP-frail

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
2
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 12 publications
0
2
0
2
Order By: Relevance
“…In a cross-sectional study conducted with an older population residing in urban areas in Minas Gerais, it was found that 51% of vulnerable older adults used at least one PIM, and 33% of participants classified as at risk of vulnerability used some PIM 22 . Furthermore, in a study conducted with an institutionalized older population in a geriatric residence in Spain, polypharmacy with PIM was prevalent in 92% of vulnerable individuals 10 . These results suggest that the higher the consumption of PIM, the higher the prevalence of vulnerability and the risk of vulnerability in older adults.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In a cross-sectional study conducted with an older population residing in urban areas in Minas Gerais, it was found that 51% of vulnerable older adults used at least one PIM, and 33% of participants classified as at risk of vulnerability used some PIM 22 . Furthermore, in a study conducted with an institutionalized older population in a geriatric residence in Spain, polypharmacy with PIM was prevalent in 92% of vulnerable individuals 10 . These results suggest that the higher the consumption of PIM, the higher the prevalence of vulnerability and the risk of vulnerability in older adults.…”
Section: Discussionmentioning
confidence: 99%
“…PIM are defined as drugs for which the probability of causing adverse effects is greater than that of providing health benefits. If used over an extended period and in excess, they can lead to pharmacological interactions, resulting in health impairments such as physical dysfunction, intoxications 6 , hospitalizations 7 , dementia 8 , renal insufficiency 9 and the frailty of older adults 10 .…”
Section: Introductionmentioning
confidence: 99%
“…Em um estudo transversal realizado com uma população idosa residente na zona urbana em Minas Gerais, foi encontrado que 51% dos idosos vulneráveis faziam uso de pelo menos 1 MPI e 33% dos participantes classificados em risco de vulnerabilidade usavam algum MPI 22 . Além disso, em um estudo realizado com uma população idosa institucionalizada em uma residência geriátrica da Espanha, polifarmácia com MPI foi prevalente em 92% dos vulneráveis 10 . Esses resultados sugerem que quanto maior o consumo de MPI maior a prevalência de vulnerabilidade e risco de vulnerabilidade em pessoas idosas.…”
Section: Discussionunclassified
“…Os MPI são definidos como fármacos em que a probabilidade de causar efeitos adversos é maior que a de benefícios para a saúde. Se utilizado de forma prolongada e em excesso podem ocasionar interações farmacológicas, trazendo prejuízos para a saúde como: disfunções físicas, intoxicações 6 , hospitalizações 7 , demência 8 , insuficiência renal 9 e a fragilidade da pessoa idosa 10 .…”
Section: Introductionunclassified